World Courier, the US-based international courier network, is targeting the booming Chinesepharmaceutical sector by extending its cold chain network to 36 major cities in the country,
including provincial capitals.“China is poised to become the fourth largest pharmaceutical market by 2012,” said HenningVoss, director for World Courier North Asia. But he noted: “China presents many infrastructurechallenges for temperature-controlled and clinical trial shipments. Domestic transport companies donot yet fully understand the many international standards at play in handling these types ofshipments. As such, the real concerns and requirements of major pharmaceutical clients in Chinahave not been adequately addressed until now.”
With its new operational network, World Courier could help pharmaceutical companies, centrallabs and clinical research organisations improve their supply chain efficiencies, Voss said. Alltemperature-sensitive pharmaceutical and clinical trial shipments are handled by trained personnelaccording to established operating practices and IATA transportation standards. Only validatedpackaging complete with industry-accepted cold-pack mediums and temperature recording devices areused.
